Oct. 4 at 5:29 PM
$IMMP
Marc Voigt mentioned before, Dr. Triebel, Immuteps Chief Scientific Officer & Executive Director, could be a Nobel prize winner.
Frédéric Triebel is a French immunologist who is best known for his 1990 discovery of the LAG3 immune control mechanism. Marc/the market has been clear this is a new checkpoint.
The last checkpoints were PD-1 and CTLA-4 for which James P. Allison and Tasuku Honjo won the Nobel prize in 2018. Keytruda being the biggest blockbuster coming forth out of that.
The Nobel Prize was awarded in 2018 to James P. Allison and Tasuku Honjo for their discovery of cancer therapy by inhibition of negative immune regulation, specifically for their independent work on CTLA-4 and PD-1 proteins, which act as "brakes" on the immune system. Honjo's discovery of the PD-1 protein was crucial, as it demonstrated that inhibiting this immune checkpoint could activate T cells to fight cancer, leading to the development of immune checkpoint inhibitors for cancer treatment.
